Interleukin 12 (Mural Oncology)

N/A

Report date: 2024/03/11 16:06:11

Base Information

Drug NameInterleukin 12 (Mural Oncology)
Drug Alias NameIL-12 (Mural Oncology)
ClassificationBiologics
Mechanisms of ActionInterleukin-12 replacements
TargetsInterleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesMural Oncology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A